Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000693764 | SCV000821645 | pathogenic | Charcot-Marie-Tooth disease, type I | 2023-01-24 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tyrosine, which is neutral and polar, with histidine, which is basic and polar, at codon 82 of the MPZ protein (p.Tyr82His). This missense change has been observed in individual(s) with late onset axonal Charcot-Marie-Tooth disease (PMID: 16543539). It has also been observed to segregate with disease in related individuals. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Tyr82 amino acid residue in MPZ. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7505151, 9633821, 12402337, 25429913). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 41017). |
Ce |
RCV001699102 | SCV002585165 | pathogenic | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | MPZ: PP1:Strong, PM2, PM5, PS4:Moderate |
Institute of Human Genetics, |
RCV003335061 | SCV004046809 | likely pathogenic | Charcot-Marie-Tooth disease dominant intermediate D | criteria provided, single submitter | not provided | ||
Institute of Human Genetics, |
RCV003444056 | SCV004171178 | likely pathogenic | Charcot-Marie-Tooth disease type 2I | criteria provided, single submitter | not provided | ||
Human Genetics Bochum, |
RCV003886367 | SCV004704563 | likely pathogenic | See cases | 2023-10-23 | criteria provided, single submitter | clinical testing | ACMG criteria used to clasify this variant: PS4_MOD, PM5, PM2_SUP, PP1, PP3 |
Gene |
RCV000033914 | SCV000057830 | not provided | Charcot-Marie-Tooth disease type 1B | no assertion provided | literature only | ||
Inherited Neuropathy Consortium | RCV000789426 | SCV000928781 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only | ||
Clinical Genetics, |
RCV001699102 | SCV001918670 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001699102 | SCV001955908 | likely pathogenic | not provided | no assertion criteria provided | clinical testing |